CYJATTA
LIVE

Serial Number

79410620

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Sep 11, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CYJATTA Trademark

Serial Number: 79410620 • Registration: 7813615

CYJATTA is a trademark filed by NOVARTIS AG on September 11, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

September 11, 2024

Registration Date

June 3, 2025

Published for Opposition

April 15, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 3, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 3, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 3, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 9, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2025 CNSA
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Mar 20, 2025 CORR
ASSIGNED TO EXAMINER
Mar 12, 2025 DOCK
CORRECTION TRANSACTION RECEIVED FROM IB
Feb 1, 2025 CRCV
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 13, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 13, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 13, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 13, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 13, 2024 COAR
APPLICATION FILING RECEIPT MAILED
Dec 6, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 6, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 28, 2024 REPR